Epidemiological and experimental evidence consistently links cannabis exposure to persistent cognitive deficits and increased psychosis risk, with adolescence as a critical vulnerability window.
Parents, adolescent health providers, policymakers, and anyone weighing cannabis use risks.
~2x psychosis risk
What the researchers found
Cannabis use is associated with dose-dependent cognitive deficits and a 2-fold or greater increase in psychosis risk. THC produces transient psychotic symptoms in healthy humans that CBD can attenuate. Adolescent exposure in rodents causes structural brain changes and impaired synaptic plasticity in fronto-limbic systems that persist into adulthood.
Why it matters
With cannabis legalization expanding, understanding who is most vulnerable to lasting harm is critical. This review marshals evidence from multiple research approaches pointing to adolescence as a particularly risky period.
The numbers in context
Cannabis use associated with approximately 2-fold increased risk of psychosis. Effects are modulated by dose, duration, age of first use, and genetic factors including shared genetic predisposition with schizophrenia.
How the study worked
Narrative review integrating epidemiological studies, experimental human studies with THC/CBD, and rodent adolescent exposure models, examining the endocannabinoid system's role in brain maturation.
What this study cannot tell us
Narrative review without systematic methodology. Causality is difficult to establish from epidemiological data alone. Genetic confounders (shared predisposition to both cannabis use and psychosis) complicate interpretation.
How to read the evidence
Strong: consistent findings across epidemiological, experimental human, and animal studies from multiple research groups.
When this study was published
Published in 2019.
The bigger picture
The endocannabinoid system plays a key role in brain maturation. Flooding it with external cannabinoids during development may permanently alter the trajectory of brain wiring, particularly in circuits responsible for higher-order thinking and emotional regulation.
Questions still open
- Can genetic screening identify individuals most at risk before cannabis exposure? Is there a safe age threshold below which all cannabis exposure carries developmental risk?
Common questions
Why are adolescents more vulnerable to cannabis effects?
Can CBD protect against THC's psychiatric effects?
Read the original research
Exposure to cannabinoids can lead to persistent cognitive and psychiatric disorders.
European journal of pain (London, England), 23(7), 1225-1233
Citation
Krebs, Marie-Odile; Kebir, Oussama; Jay, Therese M. (2019). Exposure to cannabinoids can lead to persistent cognitive and psychiatric disorders.. European journal of pain (London, England), 23(7), 1225-1233. https://doi.org/10.1002/ejp.1377
Explore the wider topic
- How THC Affects Your Amygdala: The Brain's Threat Detector and Cannabis
- The Anandamide Connection: Your Body's Natural Bliss Molecule
- How Long for Cannabinoid Receptors to Return to Normal
- Cannabis and the Developing Brain: What Every Teenager (and Parent) Should Know
- Why Can't I Enjoy Anything Without Weed? The Science Behind It
- Dopamine Recovery After Quitting Weed: What the Science Says
- The Endocannabinoid System Explained Simply: What It Does and Why It Matters
- Your Endocannabinoid System Explained: Why Withdrawal Happens
- Your Nervous System After Quitting Weed: Fight or Flight
- Using Weed Under 18: What It Does to Your Developing Brain
- What THC Does to Your Brain: Why Withdrawal Happens
- THC and Your Prefrontal Cortex: What Cannabis Does to Your Decision-Making Brain
- Weed, Cortisol, and Stress: What Cannabis Does to Your Stress Hormones
- Weed and Memory: What the Science Says About THC and Your Hippocampus
- Weed and Motivation: Is Amotivational Syndrome Real?
- Weed and Your Nervous System: What THC Actually Does to Your Brain and Body
- How Weed Rewires Your Reward System (And How to Reset It)